Lilly to cut workforce 10% in bid to save $1bn by 2011
US drugmaker Eli Lilly plans to cut 5,500 jobs by 2011 as it prepares to enter what CEO John Lechleiter said will be “the most challenging period in [the] company’s history.”
US drugmaker Eli Lilly plans to cut 5,500 jobs by 2011 as it prepares to enter what CEO John Lechleiter said will be “the most challenging period in [the] company’s history.”
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at Hovione, Agilux, McKesson and CIT.
Patheon has posted “disappointing” Q3 results, with manufacturing difficulties in Puerto Rico, a slowdown in demand for development services and reduced client demand for some products impacting on revenues.
Colorado trial support services group nSpire Health says its Koko spirometry and PiKoLogic ePro technologies were crucial factors in winning more than $9m (€6.1m) worth of clinical research contracts.
US firms Xybion Medical Systems and Locus Technology say their new animal management and data analysis partnership will help streamline preclinical development and reduce research costs.